GI & Endoscopy

Despite average prices dropping to meet a narrower market and hospital systems partnering to increase purchasing power while reimbursements are cut, the GI/endoscopic device market is expected to grow.

Colonoscopies are inaccurate in determining the proper surgical location for nearly one-third of all colon cancer cases, according to a study presented at the 2016 Digestive Disease Week, General Surgery News reports.

In an effort to expand its gastroenterology portfolio, Allergan is planning to acquire Tobira Therapeutics for up to $1.69 billion, GEN reports. Here's what you should know.

Here are three updates on gastroenterology and endoscopy companies.

A study in the Journal of Gastroenterology and Hepatology claims patients with chronic hepatitis C prefer dual oral therapy to triple therapy involving pegylated interferon, the Doctors Lounge reports.

Kristi McClellan, PA, recently joined the staff of Penn Highlands Gastroenterology, in DuBois, Pa., The Progress News reports.

NueHealth has entered a three-year partnership agreement with GeneNews — a Canadian diagnostic products company — to offer its patients early cancer detection tests.

Here are three GI-focused ASCs and facilities that recently made headlines.

A vitamin A metabolite may suppress colorectal cancer development, according to a study published in Immunity.

Three gastrointestinal disorders are associated with migraines in children and adolescents, according to a study published in The Lancet.